American National Bank & Trust’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $444K | Sell |
1,722
-191
| -10% | -$49.3K | 0.05% | 178 |
|
|
2025
Q1 | $428K | Sell |
1,913
-330
| -15% | -$73.9K | 0.05% | 161 |
|
|
2024
Q4 | $513K | Sell |
2,243
-60
| -3% | -$13.7K | 0.06% | 138 |
|
|
2024
Q3 | $562K | Sell |
2,303
-103
| -4% | -$25.1K | 0.07% | 128 |
|
|
2024
Q2 | $461K | Sell |
2,406
-10
| -0.4% | -$1.91K | 0.06% | 141 |
|
|
2024
Q1 | $478K | Sell |
2,416
-887
| -27% | -$176K | 0.06% | 139 |
|
|
2023
Q4 | $568K | Buy |
3,303
+3,080
| +1,381% | +$530K | 0.09% | 114 |
|
|
2023
Q3 | $33K | Sell |
223
-4,165
| -95% | -$616K | 0.01% | 316 |
|
|
2023
Q2 | $959K | Buy |
4,388
+1,552
| +55% | +$339K | 0.16% | 79 |
|
|
2023
Q1 | $621K | Buy |
2,836
+2,821
| +18,807% | +$618K | 0.11% | 97 |
|
|
2022
Q4 | $3K | Sell |
15
-4
| -21% | -$800 | ﹤0.01% | 470 |
|
|
2022
Q3 | $4K | Sell |
19
-1,202
| -98% | -$253K | ﹤0.01% | 437 |
|
|
2022
Q2 | $256K | Sell |
1,221
-40
| -3% | -$8.39K | 0.06% | 105 |
|
|
2022
Q1 | $306K | Sell |
1,261
-4,866
| -79% | -$1.18M | 0.06% | 106 |
|
|
2021
Q4 | $1.6M | Sell |
6,127
-274
| -4% | -$71.4K | 0.31% | 65 |
|
|
2021
Q3 | $1.69M | Buy |
6,401
+8
| +0.1% | +$2.11K | 0.37% | 50 |
|
|
2021
Q2 | $1.58M | Buy |
6,393
+1,601
| +33% | +$395K | 0.34% | 52 |
|
|
2021
Q1 | $930K | Buy |
4,792
+4,772
| +23,860% | +$926K | 0.22% | 75 |
|
|
2020
Q4 | $4K | Buy |
+20
| New | +$4K | ﹤0.01% | 206 |
|